FDA Adverse Event Injury Summary report: N

NALU NEUROSTIMULATION SYSTEM

MDR report key: 19787743 · Received July 21, 2024

Report

Report Number
3015425075-2024-00273
Event Type
Injury
Date Received
July 21, 2024
Date of Event
June 21, 2024
Report Date
July 20, 2024
Manufacturer
NALU MEDICAL INC
Product Code
GZB
UDI-DI
00812537036137
PMA / PMN Number
K183579
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THERE ARE NO RECORDS OF ANY PRIOR COMPLAINTS FROM THIS PATIENT REGARDING INADEQUATE PAIN RELIEF AND ALL FIELD EVALUATION INDICATES THE SYSTEM WAS FUNCTIONING AS EXPECTED AND PROVIDING STIMULATION TO THE APPROPRIATE LOCATION. IT IS UNLIKELY THAT THE NALU SYSTEM CAUSED NAUSEA 6 MONTHS AFTER IMPLANT. SUSPECT THERE ARE OTHER UNDERLYING ISSUES THAT CAUSED THE PATIENT TO REQUEST EXPLANT THAT ARE UNRELATED TO THE NALU SYSTEM OR ITS FUNCTION.

Description of Event or Problem · 0

PATIENT WAS IMPLANTED WITH A NALU SPINAL CORD STIMULATOR SYSTEM ON (B)(6) 2023 AFTER SUCCESSFULLY COMPLETING A TRIAL PHASE WITH THE NALU SYSTEM. DURING THE TRIAL PHASE THE PATIENT REPORTED PAIN WAS REDUCED FROM 7/10 DOWN TO 2/10 ALONG WITH A DECREASE IN PAIN MEDICATION NEEDS. THE PERMANENT SYSTEM WAS PLACED WITH THE LEADS TARGETING THE THORACIC NERVE AT THE VICINITY OF T8-T10. IN (B)(6) 2024 THE PATIENT REQUESTED TO HAVE THE SYSTEM REMOVED DUE TO REPORTS OF INADEQUATE PAIN RELIEF AND NAUSEA WHEN USING THE SYSTEM. A FULL SYSTEM EXPLANT WAS PERFORMED ON (B)(6) 2024 PER THE PATIENT REQUEST.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
965197 NALU NEUROSTIMULATION SYSTEM SPINAL CORD STIMULATOR GZB NALU MEDICAL INC 71005 00812537036137

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other